rss
Br J Ophthalmol 2010;94:584-591 doi:10.1136/bjo.2009.164780
  • Clinical science

Corneal nerve regeneration in neurotrophic keratopathy following autologous plasma therapy

  1. Kavita Rao1,
  2. Christopher Leveque2,
  3. Stephen C Pflugfelder1
  1. 1Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA
  2. 2Department of Pathology, Methodist Hospital, Houston, Texas, USA
  1. Correspondence to Dr Stephen C Pflugfelder, Ocular Surface Center, Cullen Eye Institute, Baylor College of Medicine, 6565 Fannin NC205, Houston, TX 77030, USA; stevenp{at}bcm.tmc.edu
  • Accepted 1 November 2009
  • Published Online First 3 December 2009

Abstract

Aims To evaluate the effect of topical autologous plasma on nerve morphology in patients with neurotrophic keratopathy (NK) using the confocal microscope.

Methods Eleven eyes of six patients with neurotrophic keratopathy were evaluated for this study. Corneal fluorescein staining was done, and corneal sensitivity measurements were done with the Cochet–Bonnet and modified Belmonte gas aesthesiometers. The Heidelberg Retina Tomograph 2 Rostock Cornea Module laser scanning confocal microscope was used to image the corneal surface and subepithelial neural plexus. Four images at the level of the subepithelial nerve plexus in the central cornea were randomly selected for analysis of the corneal nerves. Topical autologous plasma was used six to eight times per day.

Results The best-corrected visual acuity improved significantly after plasma treatment in all patients (p=0.003). The mean corneal fluorescein staining score significantly decreased after treatment (p=0.0003). There was a significant increase in corneal sensitivity measured by Cochet–Bonnet (p<0.0001) and modified Belmonte (p=0.01) aesthesiometers. The mean number, length, width and density of subepithelial nerves increased significantly after plasma treatment (p=0.0002).

Conclusion In vivo confocal microscopy examination revealed preliminary evidence for improvement of corneal nerve findings suggesting efficacy of autologous plasma treatment in neurotrophic keratopathy.

Footnotes

  • Funding NIH Grant EY11915 (SCP), an unrestricted grant from Research to Prevent Blindness, The Oshman Foundation, The William Stamps Farish Fund, The Hamill Foundation.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Ethics approval was provided by the Baylor College of Medicine Institutional Review Board (IRB).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.